Clinical Trial Update: Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction TP+5-FU or TP+cetuximab followed by radioimmunotherapy for locally advanced or unresectable squamous cell carcinoma in hypoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Hypopharynx
• Squamous Cell Carcinoma of the Larynx
• Squamous Cell Carcinoma of the Oral Cavity
• Squamous Cell Carcinoma of the Oropharynx

Drugs mentioned

• 5-FU (5-fluorouracil)
• Cetuximab (cetuximab)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Squamous Cell Carcinoma of the Hypopharynx Stage III, Squamous Cell Carcinoma of the Hypopharynx Stage IV | Phase 2 | Status: COMPLETED